Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Bates
Massachusetts General Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Intensix
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Bates has a financial interest in Intensix, a privately held company developing technologies related to direct patient monitoring and warning clinicians in trying to prevent clinical errors. Dr. Bates has an equity interest in this company. This research project focuses on the development and implementation of a perioperative clinical decision support tool; if successful, the research could be added to the current Intensix technology and therefore increase its value. Based on the magnitude of Dr. Bates’ financial interest in Intensix and the close connection between the company’s interests and the research, the review panel determined that the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
Preventing Perioperative Medication Errors and Adverse Drug Events Through the Use of Clinical Decision Support
Narrative In the US alone, approximately 15.75 million medication errors occur annually in operating rooms, and almost half of these lead to patient harm, with the remainder having the potential for patient harm. While not yet widely used in operating rooms, clinical decision support systems have been shown to prevent medication errors and their associated harm in other patient care areas, and have the potential to prevent more than 50% of medication errors and 95% of adverse drug events in the operating room. The goals of our proposed project are to design, build and implement platform-independent clinical decision support in the operating room setting and to evaluate whether the decision support system improves patient safety by preventing medication errors and adverse drug events.
Filed on September 30, 2016.
Tell us what you know about David Bates's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.